TLR4 and silicosis: Collectively, our work lends strong evidence to support the benefits of thalidomide in limiting ER stress, the inflammatory response, and the TLR4-NF-κB pathway activation accompanying silicosis and provides valuable insights into the mechanisms underlying the attenuation of this disease.